Hamel Lawrence G 4
4 · ACELRX PHARMACEUTICALS INC · Filed Oct 3, 2017
Insider Transaction Report
Form 4
Hamel Lawrence G
Chief Development Officer
Transactions
- Sale
Common Stock
2017-10-02$5.29/sh−10,161$53,752→ 41,964 total(indirect: See footnote)
Holdings
- 16,379
Common Stock
Footnotes (3)
- [F1]Shares sold pursuant to a 10b5-1 plan.
- [F2]The Shares were sold at prices ranging from $5.10 to $5.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The Shares are held in the Hamel Revocable Living Trust.